Intensity Therapeutics, Inc. Announces $2.35 Million Public Offering

The Series B-1 warrants will have an exercise price of $0.85 per share, will be immediately exercisable and will expire 5 years from issuance. The Series B-2 warrants will have an exercise price of $0.85 per share, will be immediately exercisable and will expire 18 months from issuance.

The Gut-Brain Axis: How Your Microbiome Could Be Shaping Your Mental Health

Microbiome

Lately, people have started to look at mental health in a much wider way, not just focusing on brain chemicals and medicines. Medication is still a big part of treatment for lots of people, but it’s becoming clear that other things also matter. Things like sleep, inflammation, and yes — the gut — are all […]

CorWave Completes 6-Month In Vivo Study for Clinical Trials Initiation

In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at explant. These significant milestones mark the final stage of CorWave’s preclinical development, paving the way for its First-In-Human study.